| 685158 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy |
2021-05-01 |
10.1136/jitc-2020-002024 |
Miyazaki Takahiro, Maiti Mekhala, Hennessy Marlene, Chang Thomas, Kuo Peiwen, Addepalli Murali, Obalapur Palakshi, Sheibani Sara, Wilczek Joanna, Pena Rhoneil, Quach Phi, Cetz Janet, Moffett Andrew, Tang Yinyan, Kirk Peter, Huang Jicai, Sheng Dawei, Zhang Ping, Rubas Werner, Madakamutil Loui, Kivimäe Saul, Zalevsky Jonathan |
| 685157 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial |
2021-05-01 |
10.1136/jitc-2020-000891corr1 |
|
| 685156 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy |
2021-05-01 |
10.1136/jitc-2020-001743 |
Nissani Abraham, Lev-Ari Shaked, Meirson Tomer, Jacoby Elad, Asher Nethanel, Ben-Betzalel Guy, Itzhaki Orit, Shapira-Frommer Ronnie, Schachter Jacob, Markel Gal, Besser Michal J. |
| 685155 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia |
2021-05-01 |
10.1136/jitc-2021-002509 |
Hoseini Sayed Shahabuddin, Vadlamudi Mallika, Espinosa-Cotton Madelyn, Tran Hoa, Feng Yi, Guo Hong-fen, Xu Hong, Cheung Irene, Cheung Nai-Kong V |
| 685154 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies |
2021-05-01 |
10.1136/jitc-2021-002555 |
Tantalo Daniela GM, Oliver Amanda J, von Scheidt Bianca, Harrison Aaron J, Mueller Scott N, Kershaw Michael H, Slaney Clare Y |
| 685153 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist |
2021-05-01 |
10.1136/jitc-2020-002214 |
Meneveau Max O, Petroni Gina R, Salerno Elise P, Lynch Kevin T, Smolkin Mark, Woodson Elizabeth, Chianese-Bullock Kimberly A, Olson Walter C, Deacon Donna, Patterson James W, Grosh William W, Slingluff Craig L |
| 685152 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer |
2021-05-01 |
10.1136/jitc-2020-002254 |
Sinha Meenal, Zhang Li, Subudhi Sumit, Chen Brandon, Marquez Jaqueline, Liu Eric V, Allaire Kate, Cheung Alexander, Ng Sharon, Nguyen Christopher, Friedlander Terence W, Aggarwal Rahul, Spitzer Matthew, Allison James P, Small Eric J, Sharma Padmanee, Fong Lawrence |
| 685151 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy |
2021-05-01 |
10.1136/jitc-2021-002392 |
Iovino Lorenzo, Thur Laurel A, Gnjatic Sacha, Chapuis Aude, Milano Filippo, Hill Joshua A |
| 685150 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation |
2021-05-01 |
10.1136/jitc-2020-001925 |
Zhou Shujuan, Meng Fanyan, Du Shiyao, Qian Hanqing, Ding Naiqing, Sha Huizi, Zhu Mei, Yu Xiaoxiao, Wang Lifeng, Liu Baorui, Wei Jia |
| 685149 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release |
2021-05-01 |
10.1136/jitc-2020-002222 |
Park Jeong A, Santich Brian H, Xu Hong, Lum Lawrence G, Cheung Nai-Kong V |
